ArticleThoracic cancer2022

Successful erlotinib rechallenge in an EGFR-mutant metastatic non-small cell lung cancer patient with afatinib-induced drug rash with eosinophilia and systemic symptoms: A case report.

Chung-Fu Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.